Websites, domains, hosts that links to bydureonhcp.com

Our database shows, that the website bydureonhcp.com is linked by a total of 6 websites.

Number of websites/domains displayed: 6
Results found: 6

Websites discovered:

Official Website for BYDUREON® (exenatide extended-release) for injectable suspension

http://pageoverview.com/website-report/bydureonfin15.com

Learn about BYDUREON, a non-insulin treatment option for adults with type 2 diabetes available in the BYDUREON Pen.

Expected expiration: December 19th in 2017
Creation date: December 19th in 2014
Renew date: June 14th in 2017

Official Website for BYDUREON® (exenatide extended-release) for injectable suspension

http://pageoverview.com/website-report/bydureonbybyby.com

Learn about BYDUREON, a non-insulin treatment option for adults with type 2 diabetes available in the BYDUREON Pen.

Expected expiration: February 25th in 2018
Creation date: February 25th in 2015
Renew date: June 14th in 2017

FARXIGA® (dapagliflozin) | Treatment for Type 2 Diabetes Mellitus in Adults

http://pageoverview.com/website-report/farxiga-hcp.com

FARXIGA® (dapagliflozin) is an SGLT2 inhibitor indicated for patients with type 2 diabetes mellitus. Explore the science behind FARXIGA.

Expected expiration: September 23rd in 2017
Creation date: September 23rd in 2013
Renew date: September 19th in 2016

Official Website for BYDUREON® (exenatide extended-release for injectable suspension)

http://pageoverview.com/website-report/bydureon.com

Learn about BYDUREON® (exenatide extended-release for injectable suspension), a non-insulin treatment option for adults with type 2 diabetes available in the BYDUREON Pen.

Expected expiration: November 15th in 2022
Creation date: November 15th in 2007
Renew date: January 29th in 2016

Official Website for BYDUREON® (exenatide extended-release) for injectable suspension

http://pageoverview.com/website-report/bydureonrhy15.com

Learn about BYDUREON, a non-insulin treatment option for adults with type 2 diabetes available in the BYDUREON Pen.

Expected expiration: December 19th in 2017
Creation date: December 19th in 2014
Renew date: June 14th in 2017

Official BYDUREON® (exenatide extended-release for injectable suspension) Healthcare Professional Website

http://pageoverview.com/website-report/bydureonhcp.com

Learn about once-weekly BYDUREON, the BYDUREON Pen, and how BYDUREON affected A1C levels and more in multiple clinical trials.

Expected expiration: February 19th in 2022
Creation date: February 19th in 2010
Renew date: January 29th in 2016